ArticleJPRAS open2025
Periorbital Necrotizing Fasciitis: Presentation to management.
Article in JPRAS open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Periorbital necrotizing fasciitis is a rare but severe infection that spreads quickly along the fascial planes, often leading to sepsis and is associated with considerable morbidity and high mortality rate. Early recognition is paramount, yet initial symptoms such as localized pain and eyelid swelling are often nonspecific. These are quickly followed by blister formation, periorbital skin and subcutaneous tissue necrosis, and systemic symptoms. Management of necrotizing fasciitis usually involves aggressive surgical debridement alongside broad-spectrum intravenous antibiotics. However, this approach is unsuitable for the periorbital area owing to the risks of eyeball exposure, decline in vision, and disfigurement. In this report, we present the case of an 85-year-old male patient who was referred to our clinic for evaluation of a suspected upper eyelid abscess, accompanied by a rapidly worsening decline in his overall clinical condition. The patient underwent 2 surgical debridements of the periorbital area, followed by reconstruction using a combination of a Mustardé cheek advancement flap and full-thickness skin graft. No surgical complications were observed, and the patient achieved aesthetic and functional improvement shortly after definitive reconstruction. Early recognition and debridement are crucial to ensure satisfactory outcomes, while reconstructive surgery techniques allow satisfactory cosmetic results.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.